Skip to main content
. Author manuscript; available in PMC: 2023 Feb 1.
Published in final edited form as: J Heart Lung Transplant. 2021 Jul 24;41(2):161–170. doi: 10.1016/j.healun.2021.07.011

Table 4.

Causes of death in patients on short-term (<1 years), mid-term (1–3 years) and long-term (≥3 years) continuous flow left ventricular assist device support. Top 7 causes of death shown.

Death with device in place <1 year (n=2693 total) Death with device in place 1–3 years (n=1567 total) Death with device in place ≥ 3 year (n=661 total)
Multisystem Organ failure
(n=577, 21.4 %)		 Neurologic
(n=296, 18.9%)		 Neurologic
(n=104, 15.7%)
Neurologic
(n=520, 19.3%)		 Withdrawal of Care
(n=204, 13.0%)		 Other
(n=102, 15.4%)
Withdrawal of care
(n=379, 14.1%)		 Other
(n=199, 12.7%)		 Heart Failure
(n=92, 13.9%)*
Heart Failure
(n=260, 9.7%)* 		Heart Failure
(n=190, 12.1%)* 		Withdrawal of care
(n=75, 11.3%)
Other
(n=186, 6.9%)		 Multisystem Organ Failure
(n=159, 10.1%)		 Multisystem Organ Failure
(n=69, 10.4%)
Respiratory
(n=155, 5.8%)		 Major Infection
(n=106, 6.8%)		 Major Infection
(n=59, 8.9%)
Major Infection
(n=148, 5.5%)		 Respiratory
(n=89, 5.7%)		 Respiratory
(n=35, 5.3%)
*

Heart failure includes right heart failure, CHF, end-stage cardiomyopathy, ischemic cardiomyopathy, and heart disease coding. LVAD= left ventricular assist device